insights_auto
Why is PTX down 5.17%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.055
arrow_downward
-5.17%(-0.0030) 1D
Oct 19, 4:10:09 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.06
Low
A$0.05
Mkt. cap
60.81M
Avg. vol.
1.02M
Volume
350.15K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.06
Low
A$0.05
Mkt. cap
60.81M
Avg. vol.
1.02M
Volume
350.15K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
investingLive
·
31 minutes ago
Nasdaq and S&P rebounds; Dow slips
TradingView
·
28 minutes ago
The Dow Jones Index Closes 0.07% Lower
Traders Union
·
24 minutes ago
Sherwin-Williams rebound signals improving momentum for Dow stock
Investing.com
·
27 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com